Level Four Advisory Services’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-13,812
| Closed | -$805K | – | 570 |
|
|
2022
Q2 | $805K | Buy |
13,812
+318
| +2% | +$18.5K | 0.08% | 254 |
|
|
2022
Q1 | $1.03M | Buy |
+13,494
| New | +$1.03M | 0.08% | 235 |
|
|
2021
Q4 | – | Sell |
-7,846
| Closed | -$439K | – | 662 |
|
|
2021
Q3 | $439K | Buy |
7,846
+1,282
| +20% | +$71.7K | 0.05% | 314 |
|
|
2021
Q2 | $398K | Buy |
6,564
+863
| +15% | +$52.3K | 0.03% | 464 |
|
|
2021
Q1 | $400K | Buy |
+5,701
| New | +$400K | 0.03% | 426 |
|